#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	13800	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2127	645.0	1	SNP	n	C1184T	0	.	.	1184	1184	C	1476	1476	C	725	C,T	680,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24726	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3661	673.1	0	.	n	.	0	T695C	SNP	695	695	T	1153	1153	C	747	C,G	704,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24726	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3661	673.1	0	.	n	.	0	G1337A	SNP	1337	1337	G	1795	1795	A	799	A,G	761,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24726	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3661	673.1	0	.	n	.	0	T1971C	SNP	1971	1971	T	2429	2429	C	685	C	641	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24726	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3661	673.1	1	SNP	n	A2045G	0	.	.	2045	2045	A	2503	2503	A	771	A,G	723,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24726	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3661	673.1	1	SNP	n	C2597T	0	.	.	2597	2597	C	3055	3055	C	797	C	746	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_L_00516	folP.WHO_L_00516	1	1	27	1956	folP	855	855	100.0	folP.l15.c4.ctg.1	1453	133.7	1	SNP	p	R229S	0	.	.	685	687	CGC	959	961	CGC	208;209;211	C;G;C	194;198;198	folP.WHO_L_00516:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4758	gyrA	2751	2751	99.89	gyrA.l15.c17.ctg.1	3203	147.6	1	SNP	p	S91F	0	.	.	271	273	TCC	494	496	TCC	160;161;164	T;C;C	150;153;157	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4758	gyrA	2751	2751	99.89	gyrA.l15.c17.ctg.1	3203	147.6	1	SNP	p	D95G	0	.	.	283	285	GAC	506	508	GAC	164;166;167	G;A;C	156;156;159	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4758	gyrA	2751	2751	99.89	gyrA.l15.c17.ctg.1	3203	147.6	1	SNP	p	D95N	0	.	.	283	285	GAC	506	508	GAC	164;166;167	G;A;C	156;156;159	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_F_01564	mtrR.WHO_F_01564	1	1	539	1530	mtrR	633	633	99.68	mtrR.l15.c4.ctg.1	1355	112.6	0	.	p	.	0	S32W	NONSYN	94	96	TCG	430	432	TGG	170;173;174	T;G;G	163;167;166	.	.
mtrR.WHO_F_01564	mtrR.WHO_F_01564	1	1	539	1530	mtrR	633	633	99.68	mtrR.l15.c4.ctg.1	1355	112.6	0	.	p	.	0	D79N	NONSYN	235	237	GAT	571	573	AAT	203;202;201	A,G;A;T	189,1;191;187	.	.
mtrR.WHO_F_01564	mtrR.WHO_F_01564	1	1	539	1530	mtrR	633	633	99.68	mtrR.l15.c4.ctg.1	1355	112.6	1	SNP	p	G45D	0	.	.	133	135	GGC	469	471	GGC	184;188;190	G;G;C	168;172;175	mtrR.WHO_F_01564:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	854	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c30.ctg.1	1112	76.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	27	4988	parC	2304	2304	99.83	parC.l15.c4.ctg.1	2989	166.1	1	SNP	p	D86N	0	.	.	256	258	GAC	620	622	GAC	182;181;185	G,A;A;C	167,1;167;173	parC.WHO_V_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	27	4988	parC	2304	2304	99.83	parC.l15.c4.ctg.1	2989	166.1	1	SNP	p	S88P	0	.	.	262	264	TCC	626	628	TCC	190;190;188	T;C;C	175;179;178	parC.WHO_V_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3938	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2508	156.1	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1456	1458	GGC	202;197;191	G;G;C	189;187;176	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.9.001	penA.9.001	1	1	27	3794	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2424	156.0	1	SNP	p	A311V	0	.	.	931	933	GCA	1267	1269	GCA	230;234;235	G;C;A	215;215;222	penA.9.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3794	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2424	156.0	1	SNP	p	I312M	0	.	.	934	936	ATC	1270	1272	ATC	237;238;241	A;T;C	226;227;227	penA.9.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3794	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2424	156.0	1	SNP	p	V316T	0	.	.	946	948	GTG	1282	1284	GTG	234;237;238	G;T;G	222;224;224	penA.9.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3794	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2424	156.0	1	SNP	p	V316P	0	.	.	946	948	GTG	1282	1284	GTG	234;237;238	G;T;G	222;224;224	penA.9.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3794	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2424	156.0	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1786	1788	ACC	201;202;201	A;C;C	174;181;179	penA.9.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3794	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2424	156.0	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1840	1842	GCG	185;186;186	G;C;G	164;156;152	penA.9.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3794	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2424	156.0	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1840	1842	GCG	185;186;186	G;C;G	164;156;152	penA.9.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3794	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2424	156.0	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1963	1965	GGC	152;146;147	G;G;C	145;140;139	penA.9.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3794	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2424	156.0	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1972	1974	GGC	149;149;149	G;G;C	141;141;143	penA.9.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3794	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2424	156.0	1	SNP	p	L552S	0	.	.	1654	1656	CTG	1990	1992	CTG	153;154;152	C,CG;T,G;G	127,1;111,1;121	penA.9.001:1:1:L552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	539	5364	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	2956	180.3	1	SNP	p	L421P	1	L421P	NONSYN	1261	1263	CTG	1484	1486	CCG	199;203;203	C;C;G	184;192;189	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2008	porA	1146	1146	99.83	porA.l15.c17.ctg.1	1913	104.5	0	.	p	.	0	S22G	NONSYN	64	66	AGC	365	367	GGC	131;129;127	G;G;C	121;119;117	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2008	porA	1146	1146	99.83	porA.l15.c17.ctg.1	1913	104.5	0	.	p	.	0	M83fs	FSHIFT	247	247	A	547	547	C	161	C	152	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2414	porB1b	1035	1035	95.51	porB1b.l15.c4.ctg.1	1514	157.9	0	.	p	.	0	T18M	NONSYN	52	54	ACG	384	386	ATG	200;198;200	A,G;T;G	191,1;191;189	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2414	porB1b	1035	1035	95.51	porB1b.l15.c4.ctg.1	1514	157.9	0	.	p	.	0	R40T	NONSYN	118	120	CGG	450	452	ACA	188;190;190	A;C;A	176;178;178	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2414	porB1b	1035	1035	95.51	porB1b.l15.c4.ctg.1	1514	157.9	0	.	p	.	0	E41D	NONSYN	121	123	GAA	453	455	GAC	189;187;190	G;A;C	178;172;176	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2414	porB1b	1035	1035	95.51	porB1b.l15.c4.ctg.1	1514	157.9	0	.	p	.	0	V45S	NONSYN	133	135	GTT	465	467	AGT	185;183;185	A;G;T	175;175;173	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2414	porB1b	1035	1035	95.51	porB1b.l15.c4.ctg.1	1514	157.9	0	.	p	.	0	G46K	NONSYN	136	138	GGC	468	470	AAA	184;184;184	A;A;A	177;177;176	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2414	porB1b	1035	1035	95.51	porB1b.l15.c4.ctg.1	1514	157.9	0	.	p	.	0	S54A	NONSYN	160	162	TCC	492	494	GCC	187;185;185	G;C;C	179;176;177	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2414	porB1b	1035	1035	95.51	porB1b.l15.c4.ctg.1	1514	157.9	0	.	p	.	0	V98I	NONSYN	292	294	GTC	624	626	ATC	205;205;203	A;T;C	189;185;187	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2414	porB1b	1035	1035	95.51	porB1b.l15.c4.ctg.1	1514	157.9	0	.	p	.	0	G189N	NONSYN	565	567	GGC	897	899	AAC	237;238;236	A,G;A,G;C	213,2;215,2;214	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2414	porB1b	1035	1035	95.51	porB1b.l15.c4.ctg.1	1514	157.9	0	.	p	.	0	I209M	NONSYN	625	627	ATC	957	959	ATG	209;212;212	A;T;G	197;197;195	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2414	porB1b	1035	1035	95.51	porB1b.l15.c4.ctg.1	1514	157.9	0	.	p	.	0	E210_Y211insK	INS	628	628	G	960	960	G	213	G	198	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2414	porB1b	1035	1035	95.51	porB1b.l15.c4.ctg.1	1514	157.9	0	.	p	.	0	.	MULTIPLE	632	633	AC	968	970	TTT	218;217;217	T;T;T	202;202;206	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2414	porB1b	1035	1035	95.51	porB1b.l15.c4.ctg.1	1514	157.9	0	.	p	.	0	N212fs	FSHIFT	634	634	A	972	972	T	213	T	199	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2414	porB1b	1035	1035	95.51	porB1b.l15.c4.ctg.1	1514	157.9	1	SNP	p	G120K	0	.	.	358	360	GGT	690	692	GGT	194;192;194	G,A;G,A;T,G	180,2;181,1;178,1	porB1b.WHO_U_02278c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2414	porB1b	1035	1035	95.51	porB1b.l15.c4.ctg.1	1514	157.9	1	SNP	p	A121N	0	.	.	361	363	GCC	693	695	GCC	193;195;193	G;C,A;C	181;186,1;185	porB1b.WHO_U_02278c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2414	porB1b	1035	1035	95.51	porB1b.l15.c4.ctg.1	1514	157.9	1	SNP	p	A121D	0	.	.	361	363	GCC	693	695	GCC	193;195;193	G;C,A;C	181;186,1;185	porB1b.WHO_U_02278c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	9474	rpoB	4179	4179	99.98	rpoB.l6.c30.ctg.1	4920	192.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1078	rpsJ	312	312	100.0	rpsJ.l15.c30.ctg.1	1163	92.6	1	SNP	p	V57M	1	.	.	169	171	ATG	597	599	ATG	238;236;237	A;T;G	227;223;227	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	7298	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2714	267.8	0	.	p	.	0	M177T	NONSYN	529	531	ATG	890	892	ACG	284;280;283	A;C;G	276;275;278	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	7298	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2714	267.8	0	.	p	.	0	Y184D	NONSYN	550	552	TAC	911	913	GAC	263;256;258	G;A;C	260;252;256	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	7298	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2714	267.8	0	.	p	.	0	T190M	NONSYN	568	570	ACG	929	931	ATG	254;251;253	A;T;G	253;247;249	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	7298	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2714	267.8	0	.	p	.	0	L194S	NONSYN	580	582	TTA	941	943	TCA	255;252;254	T;C;A	251;250;252	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	7298	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2714	267.8	0	.	p	.	0	H209Q	NONSYN	625	627	CAT	986	988	CAG	244;241;241	C;A;G	239;234;237	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	7298	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2714	267.8	0	.	p	.	0	V216L	NONSYN	646	648	GTT	1007	1009	CTT	239;238;238	C;T;T	236;235;235	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	7298	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2714	267.8	0	.	p	.	0	N223S	NONSYN	667	669	AAC	1028	1030	AGT	241;242;250	A;G,C;T	234;234,1;242	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	7298	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2714	267.8	0	.	p	.	0	Q246P	NONSYN	736	738	CAG	1097	1099	CCG	345;342;346	C,T;C;G	324,1;323;327	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	7298	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2714	267.8	0	.	p	.	0	P280S	NONSYN	838	840	CCG	1199	1201	TCG	373;372;376	T;C,T;G	351;350,1;353	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	7298	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2714	267.8	0	.	p	.	0	E337K	NONSYN	1009	1011	GAG	1370	1372	AAA	227;226;227	A;A;A	220;217;219	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	7298	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2714	267.8	0	.	p	.	0	R338K	NONSYN	1012	1014	AGA	1373	1375	AAG	224;222;220	A;A;G	217;215;214	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	7298	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2714	267.8	0	.	p	.	0	L343H	NONSYN	1027	1029	CTC	1388	1390	CAC	184;187;186	C;A;C	183;185;186	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	7298	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2714	267.8	0	.	p	.	0	Q356E	NONSYN	1066	1068	CAA	1427	1429	GAA	164;163;161	G;A;A	163;162;161	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	7298	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2714	267.8	0	.	p	.	0	A382T	NONSYN	1144	1146	GCG	1505	1507	ACG	120;121;123	A;C;G	119;120;123	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	7298	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2714	267.8	0	.	p	.	0	T399I	NONSYN	1195	1197	ACT	1556	1558	ATT	170;170;171	A;T;T	162;164;163	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	7298	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2714	267.8	0	.	p	.	0	C400S	NONSYN	1198	1200	TGT	1559	1561	AGT	172;172;172	A;G;T	165;166;165	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	7298	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2714	267.8	0	.	p	.	0	I413L	NONSYN	1237	1239	ATA	1598	1600	CTA	190;193;194	C;T;A	174;179;181	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	7298	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2714	267.8	0	.	p	.	0	K427N	NONSYN	1279	1281	AAA	1640	1642	AAT	122;121;122	A;A;T	118;117;119	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	7298	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2714	267.8	0	.	p	.	0	A450S	NONSYN	1348	1350	GCA	1709	1711	TCA	176;177;179	T;C;A	169;169;169	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	7298	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2714	267.8	0	.	p	.	0	V458M	NONSYN	1372	1374	GTA	1733	1735	ATG	186;186;187	A;T;G	178;179;180	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	7298	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2714	267.8	0	.	p	.	0	N556T	NONSYN	1666	1668	AAC	2027	2029	ACC	441;442;438	A;C;C	411;417;416	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	7298	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2714	267.8	0	.	p	.	0	K588E	NONSYN	1762	1764	AAA	2123	2125	GAA	426;427;429	G;A;A	403;404;406	.	Tetracycline resistance
